Overview
Ho Lee practices in Busan, Republic of Korea. Mr. Lee is rated as an Advanced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. His top areas of expertise are Multiple Myeloma, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Plasmacytoma, and Bone Marrow Transplant.
His clinical research consists of co-authoring 95 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Peripheral T-Cell Lymphoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaMr. Lee isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantMr. Lee isAdvanced. Learn about Bone Marrow Transplant.
- Marginal Zone Lymphoma (MZL)
- Multiple MyelomaMr. Lee isAdvanced. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaMr. Lee isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaMr. Lee isAdvanced. Learn about Peripheral T-Cell Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Mr. Lee isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisMr. Lee isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaMr. Lee isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Chronic Myelogenous Leukemia (CML)
- Diffuse Large B-Cell Lymphoma (DLBCL)